Enanta Pharmaceuticals
ENTA
$12.47
Share price
3.92%
Change (1 day)
-49.62%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) Fails to deliver data
Key failure to deliver metrics for Enanta Pharmaceuticals :
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.02 M
- Last year FTD volume: $1.06 M
Failures to deliver for Enanta Pharmaceuticals (ENTA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Enanta Pharmaceuticals (ENTA) - since 2013
Volume in USD (price x number of shares), data since 2013Enanta Pharmaceuticals (ENTA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.23 M | -84.97% |
| 2023 | $1.58 M | -69.53% |
| 2022 | $5.19 M | 37.3% |
| 2021 | $3.78 M | 22.27% |
| 2020 | $3.09 M | -14.77% |
| 2019 | $3.63 M | -54.06% |
| 2018 | $7.9 M | 134.04% |
| 2017 | $3.37 M | -70.94% |
| 2016 | $11.63 M | -27.35% |
| 2015 | $16 M | 21.11% |
| 2014 | $13.21 M | 124.82% |
| 2013 | $5.87 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $28.5 M | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $20.77 M | $81.53 M | 🇨🇭 Switzerland |
 AbbVie ABBV | $7 M | $75.1 M | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $8.02 M | $65.33 M | 🇺🇸 USA |
 Merck MRK | $5.8 M | $0.14 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.33 B | 🇺🇸 USA |